| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $272.3M | +36.4% |
| Cost of Revenue | $67.9M | +38.0% |
| Gross Profit | $204.4M | +35.9% |
| R&D Expense | $20.9M | +71.2% |
| SG&A Expense | $152.9M | +18.5% |
| Operating Income | $30.5M | +245.9% |
| Pre-tax Income | -$1.4M | +92.1% |
| Income Tax | $3.8M | +2242.2% |
| Net Income | -$5.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.9M | +54.4% |
| Accounts Receivable | $110.9M | -4.7% |
| Inventory | $13.5M | +26.4% |
| Current Assets | $211.8M | +11.7% |
| Total Assets | $399.5M | +2.7% |
| Current Liabilities | $96.3M | +5.4% |
| Long-term Debt | $250.0M | -4.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $43.9M | +297.6% |
| Capital Expenditures | $887K | -44.4% |
| Investing Cash Flow | -$5.5M | +83.5% |
| Financing Cash Flow | -$12.7M | -144.6% |
| Free Cash Flow | $43.0M | +280.6% |
| +70.6% |
| EPS (Basic) | -$0.14 | +71.4% |
| EPS (Diluted) | -$0.14 | +71.4% |
| Total Liabilities |
| $347.4M |
| +8.7% |
| Stockholders' Equity | $52.4M | -24.7% |